Evaluation of a diode array for QA measurements
on a helical tomotherapy unit
K. M. Langen,
a
S. L. Meeks, D. O. Poole, T. H. Wagner, T. R. Willoughby,
O. A. Zeidan, and P. A. Kupelian
Department of Radiation Oncology, M. D. Anderson Cancer Center Orlando, Orlando, Florida
K. J. Ruchala and G. H. Olivera
TomoTherapy Inc., Madison, Wisconsin
Received 23 May 2005; accepted for publication 1 September 2005; published 21 October 2005
A helical tomotherapy system is used in our clinic to deliver intensity-modulated radiation therapy
IMRT treatments. Since this machine is designed to deliver IMRT treatments, the traditional field
flatness requirements are no longer applicable. This allows the unit to operate without a field
flatness filter and consequently the 400 mm wide fan beam is highly inhomogeneous in intensity.
The shape of this beam profile is mapped during machine commissioning and for quality assurance
purposes the shape of the beam profile needs to be monitored. The use of a commercial diode array
for quality assurance measurements is investigated. Central axis beam profiles were acquired at
different depths using solid water built-up material. These profiles were compared with ion chamber
scans taken in a water tank to test the accuracy of the diode array measurements. The sensitivity of
the diode array to variations in the beam profile was checked. Over a seven week period, beam
profiles were repeatedly measured. The observed variations are compared with those observed with
an on-board beam profile monitor. The diode measurements were in agreement with the ion cham-
ber scans. In the high dose, low gradient region the average ratio between the diode and ion
chamber readings was 1.000± 0.005 ±1 standard deviation. In the penumbra region the agreement
was poorer but all diodes passed the distance to agreement DTA requirement of 2 mm. The trend
in the beam profile variations that was measured with the diode array device was in agreement with
the on-board monitor. While the calculated amount of variation differs between the devices, both
were sensitive to subtle variations in the beam profile. The diode array is a valuable tool to quickly
and accurately monitor the beam profile on a helical tomotherapy unit. © 2005 American Asso-
ciation of Physicists in Medicine. DOI: 10.1118/1.2089547
Key words: tomotherapy, quality assurance, diode array
I. INTRODUCTION
A TomoTherapy™ Hi
*
Art II unit delivers radiation therapy
plans using a helical tomotherapy technique.
1
A linear accel-
erator is mounted on a ring gantry that continuously rotates
while the patient is translated along the axis of gantry rota-
tion during treatment delivery. The beam has a fan geometry
and a 64 leaf binary collimator is used to subdivide this fan
beam into beamlets. Intensity modulation is achieved by a
temporal modulation of the collimator leaves.
The unit is designed for intensity modulated treatment
delivery and therefore the traditional requirement of a flat
radiation field across the treatment field does not exist any-
more. The TomoTherapy Hi
*
Art unit takes advantage of this
and a field flattening filter is omitted. The advantage of this
design is a relatively high machine output and a radiation
field that varies less in energy across the field.
1
During machine commissioning, the nonuniform beam
profile is mapped using an ion chamber scan in a water tank.
To calculate collimator leaf opening times, the relative out-
put for each leaf’s off-axis location is determined from the
beam profile and taken into account. It is therefore necessary
to periodically monitor the shape of the beam profile and to
verify its consistency. Water tank measurements are tedious
on a monthly basis and the verification of nonuniform fields
with film dosimetry requires the acquisition of a film calibra-
tion curve. The measurement of the beam profile with a com-
mercially available two-dimensional 2-D diode array was
therefore investigated. Advantages are the immediate avail-
ability of the results and ease of use.
The diode array investigated was designed for use on a
TomoTherapy unit and it is manufactured by Sun Nuclear
Corp. of Melbourne, FL. This device, henceforth referred to
as TomoDOSE™, was used for all test measurements re-
ported. First, the TomoDOSE readings are compared with
ion chamber scans in a water tank to test the diode array’s
accuracy. Second, the sensitivity of the diode array to subtle
changes in the beam profile was tested. To monitor the beam
profile, TomoTherapy’s on-board detector array can also be
used. Over the course of seven weeks, the monitoring of the
beam profile via this on-board detector array was compared
with repeated TomoDOSE measurements. Incidentally, a
continuous change in the beam profile was observed during
this period. These changes were subtle yet persistent and
were used to diagnose deterioration of the x-ray target. Prior
to this observation the x-ray target had been used for 18
months. The x-ray target was replaced at the end of the seven
week observation period.
3424 3424 Med. Phys. 32 „11…, November 2005 0094-2405/2005/32„11…/3424/7/$22.50 © 2005 Am. Assoc. Phys. Med.